...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Oral Colostrum Macrophage-activating Factor for Serious Infection and Chronic Fatigue Syndrome: Three Case Reports
【24h】

Oral Colostrum Macrophage-activating Factor for Serious Infection and Chronic Fatigue Syndrome: Three Case Reports

机译：严重感染和慢性疲劳综合症的口服初乳巨噬细胞激活因子：三例报告

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: Gc protein-derived macrophage-activating factor (GcMAF) immunotherapy has been steadily advancing over the last two decades. Oral colostrum macrophage-activating factor (MAF) produced from bovine colostrum has shown high macrophage phagocytic activity. GcMAF-based immunotherapy has a wide application for use in treating many diseases via macrophage activation or for use as supportive therapy. Results: Three case studies demonstrate that oral colostrum MAF can be used for serious infection and chronic fatigue syndrome (CFS) without adverse effects. Conclusion: We demonstrate that colostrum MAF shows promising clinical results in patients with infectious diseases and for symptoms of fatigue, which is common in many chronic diseases.
机译：背景：过去二十年来，Gc蛋白衍生的巨噬细胞激活因子（GcMAF）免疫疗法一直在稳步发展。由牛初乳产生的口服初乳巨噬细胞活化因子（MAF）显示出高的巨噬细胞吞噬活性。基于GcMAF的免疫疗法具有广泛的用途，可用于通过巨噬细胞活化治疗多种疾病或用作支持疗法。结果：三个案例研究表明，口服初乳MAF可用于严重感染和慢性疲劳综合征（CFS），而无不良影响。结论：我们证明初乳MAF在感染性疾病和疲劳症状方面显示出令人鼓舞的临床结果，这在许多慢性疾病中很常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号